News

Surgical margins for standard excision should include 9 mm of normal-appearing skin for melanoma in situs, according to a recent study.

To address the U.S. healthcare crisis, some dermatologists suggest everything from overhauling the FDA to abandoning it - and Medicare as it's currently configured. However, not all dermatologists agree with these proposals.

Tips for an efficient, harmonious office range from staying on top of patients' deductibles to taking regular four-day weekends, an expert says.

Physicians have received yet another extension in the deadline for complying with the "Red Flags" rule requiring programs to guard against identity theft. The Federal Trade Commission (FTC), the agency which developed the rule and is responsible for implementing it, announced in late July that it was moving the deadline for compliance from August 1 to November 1.

Nevi of special site can be seen not only in children and adolescents, but in adults up to age 35 as well, according to a recent study. A conservative approach to treating these nevi is justified given they do not appear to have the potential for malignancy.

Washington - The Food and Drug Administration (FDA) says an increased risk of lymphoma and other cancers is associated with the use of drugs like Remicade (Centocor) and Humira (Abbott) in children and adolescents, the Wall Street Journal reports.

Washington - The Food and Drug Administration (FDA) has approved a new warning on Allergan's Botox and a similar product about the possibility of life-threatening breathing and swallowing problems, following up on an earlier announcement about tougher warnings.

Bristol, Tenn.- The Food and Drug Administration (FDA) is reviewing a new drug application from Graceway Pharmaceuticals for imiquimod 3.75 percent using a two-week cycle regimen for treatment of actinic keratoses (AKs).

The first documented case of cutaneous polyarteritis nodosum following HPV vaccine injection suggests dermatologists should consider it as a possible vaccine-related complication, says a pathologist who worked on this case.

Making an accurate diagnosis of a given dermatosis can be easy when the clinical symptoms and the patient population are textbook presentations; however, exceptions make the rule.

In a recent case study, a patient receiving infliximab for the treatment of ulcerative colitis paradoxically developed widespread pyoderma gangrenosum lesions, a disease which normally responds well to this biologic therapy.

A recent study ushers in the era of molecular surgery as laser-assisted "nanosuturing" proves to be superior to traditional suture closing techniques not only in terms of cosmesis but also in the tensile strength and quality of wound closure. According to Dr. Sandy Tsao, who spearheaded the first human clinical trial, this novel technique is set to change the way physicians approach and manage surgical wounds in the future.

A new transforming powder dressing (Altrazeal, ULURU) is an easy-to-apply woundcare product that creates optimal conditions for healing. It has been used with excellent outcomes in a variety of acute and chronic wounds, including skin graft donor sites, pressure ulcers, venous ulcers, and diabetic foot ulcers.

Adult stem cells may have a greater role in wound healing in the future, an expert says. Researchers are conducting tissue-engineering research with bovine models to assess the feasibility of stem cells to heal wounds in bones, cartilage and tendons.

Both topical and systemic therapies are used in patients with cutaneous lupus erythematosus. According to one expert, the antimalarials are still the safest and often effective treatment approach. However, newer therapies may offer some hope in those especially challenging to treat recalcitrant cases of CLE.

The results of a recent population-based study confirms that the incidence of Cutaneous lupus erythematosus is not two to three times higher than the incidence of the more severe systemic lupus erythematosus form of the autoimmune disease, as anecdotally once thought.

Exit Accutane : Derms’ reactions mixed as Roche pulls long-standing remedy Guiding Light : Gentle, noninvasive process steers cells, researchers find Special Report : Women & Skin

World report - A 4,000-year-old skeleton discovered in Balathal, India, bearing signs of leprosy is the earliest known skeletal evidence of the disease, and is also the first evidence of leprosy in prehistoric India.The online journal PloS One published the research by Appalachian State anthropologists in May of this year.

Vascular lasers remain the gold standard for treating more severe cases of rosacea, including acne rosacea.

Systemic therapies, particularly anti-tumor necrosis factor (TNF) agents, are an appropriate course of therapy for patients with nail psoriasis.

Human skin cells exposed to the ozone in smog exhibit changes in signaling pathways that put them at increased risk for developing cancer.

Several noninvasive therapeutic approaches can be used to treat superficial basal cell carcinoma.

Recent research demonstrates the central role that signaling pathways have in achieving normal adult hair follicle cycling.

Vulvovaginal symptoms are often best diagnosed by a dermatologist, an expert says.

Findings from multiple types of studies point to IL-23 as a master cytokine in the pathogenesis of psoriasis.

While some colleagues might disagree, dermatologist Carol Lee Isaacs, M.D., thinks she lives a privileged life.

As psoriasis patients may have medical comorbidities that would have excluded them from participation in premarketing clinical trials, clinicians must turn to other sources for data to guide therapeutic decisions.

Vitamins A and C have become the frontline treatments for menopausal skin.

Women can achieve good control of adult or hormonal acne through spironolactone therapy alone or in conjunction with oral contraceptives.

Automated robotic-assisted harvesting of follicular units can significantly reduce procedure time and costs of hair transplant surgery.